Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $1.28M | +13.5K | +18.54% | $95.05 | 86.3K | May 17, 2022 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$1.28M | -10K | -11.62% | $127.97 | 76.3K | May 17, 2022 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$175K | -1.37K | -1.79% | $127.97 | 74.9K | May 17, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -13.5K | -100% | $0.00* | 0 | May 17, 2022 | Common Stock | 13.5K | $95.05 | Direct | F1 |
Id | Content |
---|---|
F1 | The SARs granted became exercisable in 25 percent increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |